Does carbonylation contribute to SERCA2a activity loss and diastolic dysfunction in a rat model of type 1 diabetes?
These data identify carbonylation as a novel mechanism that contributes to SERCA2a activity loss and diastolic dysfunction during type 1 diabetes.
CFR is diminished in patients with hypertension. The degree of CFR reduction is related to the extent of LVH.